Company intelligence / Profile preview

Nueva Vida

Ownership: Private
Development stage: Other

Overview

Nueva Vida is a nonprofit community-based organization founded in 1999 by Latina breast cancer survivors to address gaps in bilingual health services for immigrant communities. It provides outreach, education, preventive cancer screening access, patient navigation through complex care systems, and mental health support for Latinas and their families affected by cancer. The organization focuses on culturally competent care and advocacy to improve access to state-of-the-art oncology services for underserved populations.

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapy (psychosocial interventions, patient navigation)
Industry: Non-Academic Healthcare

Partnerships

Takeda Pharmaceutical Company Limited provided grant funding through its Improving Health Equity in Cancer program.Member of Metastatic Breast Cancer Alliance.Collaborates with local hospitals and community organizations.

Beyond the preview

Go deeper on Nueva Vida.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nueva Vida.

Explore the full profile